Medical Condition News

RSS

Research scientist at Kessler Foundation receives $10,000 grant to study aphasia after stroke

Olga Boukrina, PhD, research scientist in Stroke Rehabilitation Research at Kessler Foundation, has received a $10,000 grant from the Mabel H. Flory Charitable Trust.

21 Sep 2018

New findings on characteristics of Burning Mouth Syndrome

The picture is becoming clearer regarding the chronic oral pain condition known as Burning Mouth Syndrome, or BMS, which mainly affects women who are middle-aged and older. In a dissertation at Sahlgrenska Academy, additional steps are being taken toward better diagnosis and treatment.

21 Sep 2018

Study sheds light on molecular mechanisms underlying progression of prion diseases

A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

21 Sep 2018

Family history in blacks, Latinos associated with higher risk of AFib

Despite being the most common heart arrhythmia disorder in the U.S., there is not much research on the causes of atrial fibrillation in minority populations.

21 Sep 2018

Researchers identify new genetic disorder in a human patient

Researchers from Michigan State University College of Human Medicine and physicians from Spectrum Health have identified for the first time in a human patient a genetic disorder only previously described in animal models.

21 Sep 2018

Insulin treatment shows great potential against chronic bowel inflammation

Millions of people take insulin every day to treat their diabetes. But diabetes is not the only disease on which insulin has an effect, it appears.

21 Sep 2018

USC research uncovers previously unknown genetic risk factor for dementia

New research from USC has uncovered a previously unknown genetic risk factor for Alzheimer's disease and related dementias. The study provides insights on how these conditions, and other diseases of aging, might one day be treated and prevented.

21 Sep 2018

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

Combating glioblastoma remains a major challenge due the complex nature of these tumors, the inability of drugs to penetrate the brain tissue, and lack of correlation between animal models and the human condition.

21 Sep 2018

Study opens new avenues for treatment of Laing distal myopathy

New avenues are now being opened for future treatment of Laing distal myopathy, a rare disorder that causes muscles in the feet, hands and elsewhere to atrophy. In a study published in the journal PNAS, researchers have identified an enzyme with a clear link to how the disease develops.

21 Sep 2018

Study explores connection between sexuality and cognitive status in older adults

The number of people who live at home with Alzheimer's Disease (AD), a brain disease that causes abnormal changes that kill brain cells, is expected to grow from 3.2 million today to more than 8 million in 2050.

21 Sep 2018

$CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL$

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.

21 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

Belén Merck Navarro, Medicine professor at Valencia and Castellón's CEU UCH university is the only Spaniard among the 17 surgeons from 11 different countries that specialize in breast cancer who took part in a clinical trial on the usefulness of 3D images to evaluate the aesthetic results of conservative surgery in breast cancer

21 Sep 2018

Air pollution appears to be linked to increased risk of developing dementia

According to a new study co-authored by Professor Frank Kelly, School of Population Health & Environmental Sciences, air pollution appears to be linked to an increased risk of developing dementia.

21 Sep 2018

Bad air and inadequate data prove an unhealthy mix

Kira Hinslea wanted to play outside, but she knew she couldn't until her mom checked an air-quality app on her phone.

21 Sep 2018

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.

21 Sep 2018

TINY cancer detection device shows promise as point-of-care detector of KSHV

Its name is an acronym used to convey its size, but researchers at Cornell Engineering and Weill Cornell Medicine are hoping their hand-held cancer detection device's impact in the developing world is anything but small.

21 Sep 2018

Dopamine neurons may involve in conditions ranging from Parkinson's disease to schizophrenia

Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel.

21 Sep 2018

UAB researchers study dysfunction of the immune system associated with NSAID carprofen

Non-steroidal anti-inflammatory drugs, or NSAIDs, are commonly used as inflammation blockers worldwide. However, recent clinical data show these painkillers can have serious side effects that create some risk of heart attacks, strokes, and kidney or heart failure.

21 Sep 2018

New research finds that MHC-II molecules have more influence on tumors than MHC-I

Cancer immunotherapy -- efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own -- has shown great promise for some previously intractable cancers.

21 Sep 2018

Medical Condition News

Research scientist at Kessler Foundation receives $10,000 grant to study aphasia after stroke

New findings on characteristics of Burning Mouth Syndrome

Study sheds light on molecular mechanisms underlying progression of prion diseases

Family history in blacks, Latinos associated with higher risk of AFib

Researchers identify new genetic disorder in a human patient

Insulin treatment shows great potential against chronic bowel inflammation

USC research uncovers previously unknown genetic risk factor for dementia

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

Study opens new avenues for treatment of Laing distal myopathy

Study explores connection between sexuality and cognitive status in older adults

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

Air pollution appears to be linked to increased risk of developing dementia

Bad air and inadequate data prove an unhealthy mix

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

TINY cancer detection device shows promise as point-of-care detector of KSHV

Dopamine neurons may involve in conditions ranging from Parkinson's disease to schizophrenia

UAB researchers study dysfunction of the immune system associated with NSAID carprofen

New research finds that MHC-II molecules have more influence on tumors than MHC-I

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News